1 insider bought shares over the last 90 days, the latest by Snehjeev Ventures Pvt Ltd & PACs, filed 24 Aug 2026.
Amerise Biosciences: what insiders have been doing
Amerise Biosciences is a Banks company. Its directors and officers file their transactions with SEBI (PIT + SAST). The last twelve months, up to 23 October 2026, brought 5 filings signed by 1 insider.
Both sides are active: 3 purchases and 1 sale, from 1 insider and 1 insider respectively. The amount is not disclosed for 4 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
With 5 filings in twelve months, the company is more active than the median of 4 filings across the 1,892 companies we follow on the same exchange. Since 2026, the database holds 3 purchases and 1 sale by insiders of the company.
The last insider purchase was made public on 24 August 2026, 76 days ago. Most trades are made public on the day they happen. This delay matters because a trade only becomes useful information once it is public.
In the same sector, recent insider purchases at ASR Nederland N.V. and Avarda Bank AB also feature in our signals. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Who traded when
BuySaleFinancial data
as of FY 2026FY ended March 2026 · cache
- 76,725 shares-MarketSEBI:a083e52395d33aa0ce4ff001a12a702e66037790Canonical exit: 22 Nov 2026 (T+90)
- 318,285 shares-MarketSEBI:046f83ee7d2cddf545940e719dd37501c3e08294
- 38,574 shares-MarketSEBI:bee040cfeec8fcc087f55854461a58606e7be976Canonical exit: 28 Oct 2026 (T+90)
- 28,000 shares-MarketSEBI:4d4e98be6cc61301f2b4c2e07591912180e635ffCanonical exit: 28 Oct 2026 (T+90)
- 32,000 shares-MarginSEBI:9ed982e0be185f2de13c0ce46df66f8601256f51
5 of 5 declarations
About Amerise Biosciences
Amerise Biosciences is a company focused on developing innovative biopharmaceutical solutions. It operates in the XBOM market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
